Follow
Melyssa Bratton
Melyssa Bratton
Manager, Biospecimen & Core Research Laboratory, Ochsner Health
Verified email at ochsner.org
Title
Cited by
Cited by
Year
Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer
LV Rhodes, SP Short, NF Neel, VA Salvo, Y Zhu, S Elliott, Y Wei, D Yu, ...
Cancer research 71 (2), 603-613, 2011
1792011
Endocrine disruptor regulation of microRNA expression in breast carcinoma cells
SL Tilghman, MR Bratton, HC Segar, EC Martin, LV Rhodes, M Li, ...
PloS one 7 (3), e32754, 2012
1782012
Proteomic analysis of acquired tamoxifen resistance in MCF-7 cells reveals expression signatures associated with enhanced migration
C Zhou, Q Zhong, LV Rhodes, I Townley, MR Bratton, Q Zhang, EC Martin, ...
Breast Cancer Research 14, 1-21, 2012
1322012
Suicide Inactivation of Cytochrome c Oxidase:  Catalytic Turnover in the Absence of Subunit III Alters the Active Site
MR Bratton, MA Pressler, JP Hosler
Biochemistry 38 (49), 16236-16245, 1999
1321999
Regulation of ERα-mediated transcription of Bcl-2 by PI3K-AKT crosstalk: Implications for breast cancer cell survival
MR Bratton, BN Duong, S Elliott, CB Weldon, BS Beckman, JA McLachlan, ...
International journal of oncology 37 (3), 541-550, 2010
952010
Fulvestrant-3 boronic acid (ZB716): an orally bioavailable selective estrogen receptor downregulator (SERD)
J Liu, S Zheng, VL Akerstrom, C Yuan, Y Ma, Q Zhong, C Zhang, Q Zhang, ...
Journal of medicinal chemistry 59 (17), 8134-8140, 2016
782016
Proteomic signatures of acquired letrozole resistance in breast cancer: suppressed estrogen signaling and increased cell motility and invasiveness
SL Tilghman, I Townley, Q Zhong, PP Carriere, J Zou, SD Llopis, ...
Molecular & Cellular Proteomics 12 (9), 2440-2455, 2013
592013
Pharmacological inhibition of sphingosine kinase isoforms alters estrogen receptor signaling in human breast cancer
JW Antoon, WD Meacham, MR Bratton, EM Slaughter, LV Rhodes, ...
Journal of molecular endocrinology 46 (3), 205-216, 2011
592011
Glyceollins as novel targeted therapeutic for the treatment of triple-negative breast cancer
LV Rhodes, SL Tilghman, SM Boue, S Wang, H Khalili, SE Muir, ...
Oncology letters 3 (1), 163-171, 2012
532012
Identification of the Structural Subunits Required for Formation of the Metal Centers in Subunit I of Cytochrome c Oxidase of Rhodobacter sphaeroides
MR Bratton, L Hiser, WE Antholine, C Hoganson, JP Hosler
Biochemistry 39 (42), 12989-12995, 2000
512000
The Organochlorine o,p’-DDT Plays a Role in Coactivator-Mediated MAPK Crosstalk in MCF-7 Breast Cancer Cells
MR Bratton, DE Frigo, HC Segar, KP Nephew, JA McLachlan, TE Wiese, ...
Environmental health perspectives 120 (9), 1291-1296, 2012
452012
AKT regulation of estrogen receptor β transcriptional activity in breast cancer
BN Duong, S Elliott, DE Frigo, LI Melnik, L Vanhoy, S Tomchuck, ...
Cancer research 66 (17), 8373-8381, 2006
452006
Effects of SDF-1–CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells
LV Rhodes, MR Bratton, Y Zhu, SL Tilghman, SE Muir, VA Salvo, CR Tate, ...
Experimental cell research 317 (18), 2573-2581, 2011
422011
Comparative proteomic analyses of human adipose extracellular matrices decellularized using alternative procedures
C Thomas‐Porch, J Li, F Zanata, EC Martin, N Pashos, K Genemaras, ...
Journal of biomedical materials research Part A 106 (9), 2481-2493, 2018
412018
Organochlorine-mediated potentiation of the general coactivator p300 through p38 mitogen-activated protein kinase
MR Bratton, DE Frigo, KA Vigh-Conrad, D Fan, S Wadsworth, ...
Carcinogenesis 30 (1), 106-113, 2009
362009
Rational design of a boron-modified triphenylethylene (GLL398) as an oral selective estrogen receptor downregulator
J Liu, S Zheng, S Guo, C Zhang, Q Zhong, Q Zhang, P Ma, EV Skripnikova, ...
ACS Medicinal Chemistry Letters 8 (1), 102-106, 2017
342017
Obesity-Altered Adipose Stem Cells Promote ER+ Breast Cancer Metastasis through Estrogen Independent Pathways
RA Sabol, A Beighley, P Giacomelli, RM Wise, MAA Harrison, ...
International journal of molecular sciences 20 (6), 1419, 2019
322019
ZB716, a steroidal selective estrogen receptor degrader (SERD), is orally efficacious in blocking tumor growth in mouse xenograft models
S Guo, C Zhang, M Bratton, M Mottamal, J Liu, P Ma, S Zheng, Q Zhong, ...
Oncotarget 9 (6), 6924, 2018
322018
Phytoalexins, miRNAs and breast cancer: a review of phytochemical-mediated miRNA regulation in breast cancer
SL Tilghman, LV Rhodes, MR Bratton, P Carriere, LC Preyan, SM Boue, ...
Journal of health care for the poor and underserved 24 (1 0), 36, 2013
322013
Insulin-like growth factor-1 signaling regulates miRNA expression in MCF-7 breast cancer cell line
EC Martin, MR Bratton, Y Zhu, LV Rhodes, SL Tilghman, ...
PloS one 7 (11), e49067, 2012
322012
The system can't perform the operation now. Try again later.
Articles 1–20